TheraRadar
← Back
Data updated: Mar 29, 2026

SHANDONG XINHUA

Pharmaceuticals
Generics

SHANDONG XINHUA is a generic drug manufacturer with 3 FDA-approved products.

2016
Since
3
Drugs
-
Trials
91
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

ATORVASTATIN CALCIUM 2026-01-22
Manufacturing (CMC)
ATORVASTATIN CALCIUM 2025-12-31
Labeling
ATORVASTATIN CALCIUM 2025-11-13
SEVELAMER CARBONATE 2025-10-27
IBUPROFEN 2025-04-29
Manufacturing (CMC)
SEVELAMER CARBONATE 2025-04-24
Labeling
IBUPROFEN 2025-04-01
Labeling
IBUPROFEN 2025-04-01
Labeling
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

No indication data

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...